Skip to content
Friday, January 23, 2026
Latest:
  • In Vivo Assessment of Visual Performance in Mice
  • Journal Club: Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration
  • Breakthroughs in Cervical Cancer Research Using Cellendes’ Advanced 3-D Life Hydrogel Products
  • AstraZeneca Acquires Modella AI to Expand Oncology AI Capabilities
  • Advanced Dual-Channel Microfluidic Platform 

Pharma Industry Review

Pharma Industry Review

Pharma Industry Review

  • Products
  • Companies
    • Find Suppliers
    • Press Releases
    • Downloads
    • Videos
    • Sponsored
  • Resources
  • Sectors
    • Preclinical Studies
    • Drug Discovery
    • Drug Development
    • Clinical Trials
    • Diagnostics
    • Manufacturing
    • Supply Chain
    • Regulatory
    • Artificial Intelligence (AI)
    • Digitalization
  • RESEARCH AREAS
    • Oncology
    • Immunology
    • Infectious Diseases
      • COVID-19
    • Neurology
      • Alzheimer’s
      • CNS
      • Parkinson’s
    • Respiratory
    • Fibrotic Diseases
    • Renal Diseases
    • Inflammatory Diseases
    • Vascular Diseases
    • Metabolic
  • Investment
    • Stocks
    • Deals
  • Projects

Clinical Trials

Clinical Trials COVID-19 DISEASES Infectious Diseases Latest 

Merck and Ridgeback’s Oral Antiviral Molnupiravir Can Halve COVID-19 Risk of Hospitalisation

October 2, 2021October 7, 2021 Pharmaceutical Industry Editor

Interim Analysis of Phase 3 Study shows Merck and Ridgeback’s investigational oral antiviral Molnupiravir has reduced the risk of hospitalization

Read more
Clinical Trials Oncology 

Phase 3 Results for Adjuvant Treatment with Merck’s KEYTRUDA® Show Superior RFS in Patients With Resected High-Risk Stage II Melanoma

September 19, 2021September 19, 2021 Pharmaceutical Industry Editor Adjuvants, monoclonal antibodies

Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced on Saturday the first results from the

Read more
decorative
Clinical Trials DISEASES Immunology 

First Celiac Disease Patient Dosed in Calypso IL-15 Monoclonal Antibody Trial

September 9, 2021September 11, 2021 Pharmaceutical Industry Editor antibodies, monoclonal antibodies

Calypso Biotech, a leading biotechnology company in the development of Interleukin-15 (IL-15) targeted therapies, announces today completion of the dosing

Read more
Clinical Trials COVID-19 DISEASES Immunology Infectious Diseases Latest 

Vaxzevria Highly Effective against Beta/Gamma and Delta Variants

July 23, 2021October 8, 2021 Pharmaceutical Industry Editor recombinant adenovirus vectors, vaccine development, viral vector

Real-world data has shown the Vaxzevria vaccine (formerly AZD1222), co-developed by AstraZeneca, the University of Oxford and its spin-out company,

Read more
Clinical Trials DISEASES Infectious Diseases Latest 

University of Oxford Starts Phase I Clinical Trial of Novel HIV Vaccine

July 8, 2021July 8, 2021 Pharmaceutical Industry Editor HIV

The University of Oxford has commenced a Phase I clinical trial of a novel HIV vaccine candidate with vaccinations underway

Read more
decorative
Clinical Trials Digitalization 

IQVIA Launches Clinical Data Analytics Suite (CDAS) for Smarter, Faster Clinical Trials

June 25, 2021June 25, 2021 Pharmaceutical Industry Editor Artificial Intelligence (AI)

IQVIA™ has launched it’s Clinical Data Analytics Suite (CDAS), a new SaaS-based clinical data analytics platform that combines structured and

Read more
decorative
Clinical Trials Oncology 

Aleta Biotherapeutics and Cancer Research UK Collaborate to Advance Blood Cancer Therapy

June 23, 2021June 23, 2021 Pharmaceutical Industry Editor T-cell

Aleta Biotherapeutics (‘Aleta’) and Cancer Research UK today announced a partnership to advance the early phase clinical development of Aleta’s

Read more
Clinical Trials 

Altasciences and SiteOne Start Phase I Study of Non-Opioid Analgesic for Acute Pain

May 15, 2021May 15, 2021 Pharmaceutical Industry Editor

The award-winning Contract Research Organisation (CRO) Altasciences will initiate a Phase I Study in healthy normal subjects for ST-2427, a

Read more
covid-19 treatment clinical trial
Clinical Trials COVID-19 DISEASES Infectious Diseases 

Xenothera and Excelya Start European Clinical Trial for COVID Treatment XAV-19

May 4, 2021May 4, 2021 Pharmaceutical Industry Editor antibodies

The COVID-19 treatment XAV-19, developed by French biotech company XENOTHERA, has started a European clinical trial in partnership with Contract

Read more
Clinical Trials Immunology Oncology 

BMY’s Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves pCR for Resectable NSCLC in Phase 3 Trial

April 11, 2021April 11, 2021 Pharmaceutical Industry Editor Adjuvants

Bristol Myers Squibb announced positive results from a Phase 3 Trial, which showed that neoadjuvant treatment with three cycles of

Read more
  • ← Previous
  • Next →
Ticker Tape by TradingView

DON’T MISS A THING


We don’t spam! Please read our Privacy Policy for more info.


Thanks! Finally, please check your inbox or spam folder to confirm your subscription.

Advertisement

Featured Company

    • cropped BeOnChip logo 2 3 1 768x458

    Beonchip

    Category: 3D Drug Screening, Cell Line Development, Drug Discovery, Laboratory Equipment, Organ-on-chip and Preclinical Toxicology
    Next-Gen In Vitro Microfluidic Platforms Details Products Downloads Videos Press Releases Contact Details Beonchip is pioneering the next generation of in vitro microfluidic platforms, empowering pharmaceutical, biotech, and academic researchers to advance drug discovery and preclinical development.With its innovative Organ-on-Chip technology, Beonchip bridges the gap between conventional cell culture and real-life physiology, offering systems that replicate the complexity of human Read more…

Featured Product

Assessment of Visual Performance in Mice
Neurology Preclinical Studies Products R&D 

In Vivo Assessment of Visual Performance in Mice

January 22, 2026January 22, 2026 Pharmaceutical Industry Editor

The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for

LATEST

Assessment of Visual Performance in Mice
Neurology Preclinical Studies Products R&D 

In Vivo Assessment of Visual Performance in Mice

January 22, 2026January 22, 2026 Pharmaceutical Industry Editor

The unique OptoDrum device for automated in vivo assessment of visual performance in mice and rats offers unmatched capabilities for

decorative
Latest Neurology Press Releases R&D Sponsored 

Journal Club: Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration

January 22, 2026January 22, 2026 Pharmaceutical Industry Editor
decorative
Oncology Press Releases R&D 

Breakthroughs in Cervical Cancer Research Using Cellendes’ Advanced 3-D Life Hydrogel Products

January 14, 2026January 14, 2026 Pharmaceutical Industry Editor
decorative
Drug Discovery Latest Oncology 

AstraZeneca Acquires Modella AI to Expand Oncology AI Capabilities

January 14, 2026January 14, 2026 Pharmaceutical Industry Editor
Dual-Channel Microfluidic Platform
Products 

Advanced Dual-Channel Microfluidic Platform 

January 13, 2026January 13, 2026 Pharmaceutical Industry Editor
easy-to-use microfluidic platform for 2D cell culture under flow
Products 

Easy-to-Use Microfluidic Platform for Cell Culture Under Flow

January 13, 2026January 13, 2026 Pharmaceutical Industry Editor
Electrochemical Gradient Microfluidic Platform for 3D Cell and Barrier Models
Products 

Electrochemical Gradient Microfluidic Platform for 3D Cell and Barrier Models

January 13, 2026January 13, 2026 Pharmaceutical Industry Editor
Microfluidic Platform for ALI
Products 

Versatile Microfluidic Platform for ALI and Barrier Research

January 13, 2026January 13, 2026 Pharmaceutical Industry Editor
microfluidic chip accessories
Products 

Microfluidic Chip Accessories – Beonchip

January 13, 2026January 13, 2026 Pharmaceutical Industry Editor
decorative
Latest Metabolic R&D 

Lilly Doubles Down on Nimbus in $1.3B Oral Obesity Pact

January 7, 2026January 7, 2026 Pharmaceutical Industry Editor
decorative
Comments & Analysis DISEASES Neurology Sponsored 

Alpha-Synuclein Aggregation: A Key Target in the Battle Against Parkinson’s Disease

January 7, 2026January 7, 2026 Pharmaceutical Industry Editor
Device for Visual Acuity Testing of Laboratory Animals
Neurology Preclinical Studies Products 

Device for Visual Acuity Testing of Laboratory Animals

January 6, 2026January 6, 2026 Pharmaceutical Industry Editor
Sanofi Strengthens Vaccine Portfolio with $2.2B Dynavax Acquisition
Deals Infectious Diseases Latest 

Sanofi Strengthens Vaccine Portfolio with $2.2B Dynavax Acquisition

January 4, 2026January 4, 2026 Pharmaceutical Industry Editor
decorative
Latest Regulatory 

FDA Approves Novo’s Wegovy® Pill as First Oral GLP-1 Weight Loss Therapy

December 28, 2025December 28, 2025 Pharmaceutical Industry Editor
decorative pdf download icon
Case Studies Downloads Preclinical Studies 

A Game-Changer in Predicting Drug-Induced Gastrointestinal Toxicity

December 11, 2025January 6, 2026 Pharmaceutical Industry Editor
Dual REFRIGERATED and DEEP-FREEZE CONTAINER 10.10
Products Supply Chain 

Dual Refrigerated and Deep-Freezer Containers

December 11, 2025December 11, 2025 Pharmaceutical Industry Editor
Eli Lilly to Invest $6 Billion in New API Manufacturing Facility in Alabama, USA
Latest Manufacturing Projects 

Eli Lilly to Invest $6 Billion in New API Manufacturing Facility in Alabama, USA

December 11, 2025December 11, 2025 Pharmaceutical Industry Editor

Advertisement

About Us

Logo
Pharma Industry Review is here to provide you with the latest news, reviews and insights from the pharmaceutical industry so that you can take your business one step ahead.

About Us

  • Advertise
  • Contact Us
  • Editorial Standards
  • Terms & Conditions
  • Privacy Policy

Useful Links

  • Client Portal
  • Presentation Portal
  • Sectors
  • Projects
  • RSS Feed

RSS Feed

Copyright © 2026 Pharma Industry Review. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits, according to our Privacy Policy. You can enable the specific cookies from Settings or consent to the use of ALL the cookies.
.
Cookie settingsACCEPT ALL
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
__hssc30 minutesThis cookie is set by HubSpot. The purpose of the cookie is to keep track of sessions. This is used to determine if HubSpot should increment the session number and timestamps in the __hstc cookie. It contains the domain, viewCount (increments each pageView in a session), and session start timestamp.
na_id1 year 1 monthThis cookie is set by Addthis.com to enable sharing of links on social media platforms like Facebook and Twitter
na_rn1 monthThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_sc_e1 monthThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_sr1 monthThis cookie is set by Addthis.com. This cookie is used for sharing of links on social media platforms.
na_srp1 minuteThis cookie is used to recognize the visitor upon re-entry. This cookie allows to collect information on user behaviour and allows sharing function provided by Addthis.com
na_tc1 year 1 monthThis cookie is set by the provider Addthis. This cookie is used for social media sharing tracking service.
ouid1 year 1 monthThe cookie is set by Addthis which enables the content of the website to be shared across different networking and social sharing websites.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
CookieDurationDescription
d3 monthsThis cookie tracks anonymous information on how visitors use the website.
YSCsessionThis cookies is set by Youtube and is used to track the views of embedded videos.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
__gads1 year 24 daysThis cookie is set by Google and stored under the name dounleclick.com. This cookie is used to track how many times users see a particular advert which helps in measuring the success of the campaign and calculate the revenue generated by the campaign. These cookies can only be read from the domain that it is set on so it will not track any data while browsing through another sites.
__hstc1 year 24 daysThis cookie is set by Hubspot and is used for tracking visitors. It contains the domain, utk, initial timestamp (first visit), last timestamp (last visit), current timestamp (this visit), and session number (increments for each subsequent session).
_ga2 yearsThis cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_149839117_11 minuteGoogle uses this cookie to distinguish users.
_gid1 dayThis cookie is installed by Google Analytics. The cookie is used to store information on how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
hubspotutk1 year 24 daysThis cookie is used by HubSpot to keep track of the visitors to the website. This cookie is passed to Hubspot on form submission and used when deduplicating contacts.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
CookieDurationDescription
ab1 yearThis domain of this cookie is owned by agkn. The cookie is used for targeting and advertising purposes.
CMID1 yearThe cookie is set by CasaleMedia. The cookie is used to collect information about the usage behavior for targeted advertising.
CMPRO3 monthsThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMPS3 monthsThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMRUM31 yearThis cookie is set by Casalemedia and is used for targeted advertisement purposes.
CMST1 dayThe cookie is set by CasaleMedia. The cookie is used to collect information about the usage behavior for targeted advertising.
DSID1 hourThis cookie is setup by doubleclick.net. This cookie is used by Google to make advertising more engaging to users and are stored under doubleclick.net. It contains an encrypted unique ID.
id1 year 1 monthThe main purpose of this cookie is targeting and advertising. It is used to create a profile of the user's interest and to show relevant ads on their site. This Cookie is set by DoubleClick which is owned by Google.
IDE1 year 24 daysUsed by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
KADUSERCOOKIE3 monthsThe cookie is set by pubmatic.com for identifying the visitors' website or device from which they visit PubMatic's partners' website.
KTPCACOOKIE1 dayThis cookie is set by pubmatic.com for the purpose of checking if third-party cookies are enabled on the user's website.
mc1 year 1 monthThis cookie is associated with Quantserve to track anonymously how a user interact with the website.
mdata1 year 1 monthThe domain of this cookie is owned by Media Innovation group. This cookie registers a unique ID used to identify a visitor on their revisit inorder to serve them targeted ads.
ov1 year 1 monthThis cookie is set by the provider mookie1.com. This cookie is used for serving the user with relevant content and advertisement.
pxrc2 monthsThe purpose of the cookie is to identify a visitor to serve relevant advertisement.
rlas31 yearThe cookie is set by rlcdn.com. The cookie is used to serve relevant ads to the visitor as well as limit the time the visitor sees an and also measure the effectiveness of the campaign.
test_cookie15 minutesThis cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
uid1 year 1 monthThis cookie is used to measure the number and behavior of the visitors to the website anonymously. The data includes the number of visits, average duration of the visit on the website, pages visited, etc. for the purpose of better understanding user preferences for targeted advertisments.
uuid3 monthsTo optimize ad relevance by collecting visitor data from multiple websites such as what pages have been loaded.
uuid23 monthsThis cookies is set by AppNexus. The cookies stores information that helps in distinguishing between devices and browsers. This information us used to select advertisements served by the platform and assess the performance of the advertisement and attribute payment for those advertisements.
VISITOR_INFO1_LIVE5 months 27 daysThis cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
CookieDurationDescription
anj3 monthsNo description
CONSENT16 years 9 months 12 days 8 hoursNo description
cookielawinfo-checkbox-functional1 yearThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-others1 yearNo description
GoogleAdServingTestsessionNo description
i1 yearThe purpose of the cookie is not known yet.
u1 yearThe purpose of this cookie is targeting and marketing.The domain of this cookie is related with a company called Bombora in USA.
SAVE & ACCEPT
Powered by CookieYes Logo